Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026

Go back to Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
(NASDAQ: TRVI) Delayed: 14.81 -0.14 (0.94%)
Previous Close $14.95    52 Week High
Open $14.96    52 Week Low
Day High $15.11    P/E N/A 
Day Low $14.70    EPS
Volume 233,953